Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro getmixapp
Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro getmixapp
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a new human pathogen in late 2019 and has infected an estimated 10% of the global population in less than a year. There is a clear need for effective antiviral drugs to complement current preventive measures including vaccines. In this study, we demonstrate that berberine and obatoclax, two broad-spectrum antiviral compounds,...
Source:
mix.com
You've added this content to your favorites.
Post your comment
Load More
